Watsco WSO · NYSE
$303.66 +0.22% (+$0.66)
Summary
64 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 12 years in a row.
- It earns 13 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 7.4% a year over the last 3 years.
- It pays out more in dividends than it earns: 114% of profit.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.9 USD for 1 USD of yearly profit. Over the last five years it was 25.9 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.4% a year over 5 years. Over the last 3 years it fell by 0.2% a year. For the next fiscal year analysts expect revenue to grow by 5.6%. Earnings per share fell by 7.4% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 73 USD
- Sales and administration 18 USD
- Taxes and other 2.7 USD
- Net profit 6.3 USD
Net profit, industry median (Industrial - Distribution) 4.1 USD
Out of every 100 USD of revenue, 6.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 4.26%
- Paid out of profit
- 114%
- Raised in a row
- 12 years
You receive $12.90 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 17
- Sell 2
Today's price within the analysts' price targets
The average target of $386.25 is 27% above today's price. 30% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- UNITED STATES 90%
- Latin America and Caribbean 5.3%
- CANADA 4.7%
UNITED STATES brings in 90% of revenue.
Segments in detail